Twenty years ago, in 2025, Professor Derya Unutmaz stunned his audience when he predicted that we would solve the problem of human aging by 2045. Many people scoffed at this idea, but secretly hoped that his prediction would in fact come true.

What the doubters failed to fully consider was the exponential acceleration of scientific progress powered by AI, and in particular, biotech and life sciences. Retro Biosciences, founded with the fairly modest goal of extending our lifespans by 10 years, deployed GPT-4b to supercharge their research efforts. Almost immediately, the bio-AI was able to accelerate optimization of the Yamanaka factors to turn adult cells back into stem cells, to rejuvenate tissues and organs.

But it was the release of the LIFE (Longevity Intelligence for Everyone) model by DeepSeek that really got the industry buzzing. Dozens of startups, lured by the promise of a trillion-dollar industry, poured their hearts and minds into solving the problem of biological complexity. With the help of AI, it’s possible to compress a lifetime of research into years or months, and quickly discard the less promising pathways.

Using massive amounts of genomic data, LIFE AI is able to identify vulnerabilities in individual DNA profiles, and suggest optimal genetic treatment regimes. Not only to cure or prevent disease, but to delay or even reverse aging at the cellular level.

As Futureworld futurist Doug Vining was fond of saying back in the day: “The ultimate cure for aging is DATA.” And the ability to turn that data into solutions, through simulation and experimentation, that only AI could do at exponential scale.

Now we are reaching ‘longevity escape velocity’ and can keep aging at bay, indefinitely. The AI won’t let you die. Unless you choose to.